In a study published in the Journal of Cancer Survivorship, researchers found that cognitive impairment (and memory loss randing from minor to acute) was one of the most frequently reported post-treatment side effects in breast cancer survivors. This collection of symptoms, referred to colloquially as ‘chemobrain’, is not unique to breast cancer patients- and only recently has it been taken seriously by the medical community as a whole.

Click here to read the original article.